VERONAPHARMA.COM: Keyword Density Checker

Total words: 1591 | 2-word phrases: 411 | 3-word phrases: 467 | 4-word phrases: 482

PAGE INFO

Title	Try to keep the title under 60 characters (49 characters) Verona Pharma \| Innovative Respiratory Treatments
Description	Try to keep the meta description between 50 - 160 characters (233 characters) Verona Pharma develops novel treatments like ensifentrine in COPD. Future development is focused on chronic lung diseases such as COPD, asthma, and cystic fibrosis. Explore our advancements, patient insights, and latest investor news
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (56 characters) Breathing life into the treatment of respiratory disease

#	Keyword	Frequency	Density
1	learn more patient	3	0.64%
2	financial results shareholder	3	0.64%
3	results shareholder information	3	0.64%
4	stock information newssec	3	0.64%
5	shareholder information analyst	3	0.64%
6	information analyst coverage	2	0.43%
7	product our science	2	0.43%
8	9 2024 verona	2	0.43%
9	presentationspublications past events	2	0.43%
10	read more may	2	0.43%
11	events upcoming events	2	0.43%
12	our science patient	2	0.43%
13	strategy company leadership	2	0.43%
14	is now approved	2	0.43%
15	careers corporate governance	2	0.43%
16	corporate governance compliance	2	0.43%
17	update read more	2	0.43%
18	past events upcoming	2	0.43%
19	may 9 2024	2	0.43%
20	information learn more	2	0.43%
21	financial results and	2	0.43%
22	and provides corporate	2	0.43%
23	pipeline focus areas	2	0.43%
24	focus areas research	2	0.43%
25	areas research and	2	0.43%
26	information newssec filings	2	0.43%
27	results and provides	2	0.43%
28	site learn more	2	0.43%
29	quarter 2024 financial	2	0.43%
30	investors stock information	2	0.43%

#	Keyword	Frequency	Density
1	results shareholder information analyst	3	0.62%
2	financial results shareholder information	3	0.62%
3	past events upcoming events	2	0.41%
4	results and provides corporate	2	0.41%
5	financial results and provides	2	0.41%
6	2024 financial results and	2	0.41%
7	shareholder information analyst coverage	2	0.41%
8	careers corporate governance compliance	2	0.41%
9	quarter 2024 financial results	2	0.41%
10	stock information newssec filings	2	0.41%
11	investors stock information newssec	2	0.41%
12	resources investors stock information	2	0.41%
13	information learn more patient	2	0.41%
14	focus areas research and	2	0.41%
15	pipeline focus areas research	2	0.41%
16	9 2024 verona pharma	2	0.41%
17	may 9 2024 verona	2	0.41%
18	presentationspublications past events upcoming	2	0.41%
19	cystic fibrosis asthma patients	1	0.21%
20	fibrosis asthma patients empowering	1	0.21%
21	patients empowering respiratory patients	1	0.21%
22	bronchiectasis cystic fibrosis asthma	1	0.21%
23	noncf bronchiectasis cystic fibrosis	1	0.21%
24	respiratory patients understanding the	1	0.21%
25	patients understanding the impact	1	0.21%
26	understanding the impact of	1	0.21%
27	lungs learn more copd	1	0.21%
28	search product our science	1	0.21%
29	the lungs learn more	1	0.21%
30	of the lungs learn	1	0.21%
31	out of the lungs	1	0.21%
32	and out of the	1	0.21%
33	in and out of	1	0.21%
34	air in and out	1	0.21%
35	move air in and	1	0.21%
36	to move air in	1	0.21%
37	harder to move air	1	0.21%
38	the impact of chronic	1	0.21%
39	empowering respiratory patients investors	1	0.21%
40	impact of chronic respiratory	1	0.21%

#	URL	Whois	Check
1	https://ohtuvayrehcp.com/files/Ohtuvayre-US-Prescribing-Information.pdf	Whois	ohtuvayrehcp.com
2	https://ohtuvayrehcp.com/files/Ohtuvayre-US-Prescribing-Information.pdf	Whois	ohtuvayrehcp.com
3	https://ohtuvayre.com/files/Ohtuvayre-US-Prescribing-Information.pdf#page=13	Whois	ohtuvayre.com
4	https://ohtuvayre.com/files/Ohtuvayre-US-Prescribing-Information.pdf#page=13	Whois	ohtuvayre.com
5	https://ohtuvayre.com	Whois	ohtuvayre.com
6	https://ohtuvayre.com	Whois	ohtuvayre.com
7	https://ohtuvayrehcp.com	Whois	ohtuvayrehcp.com
8	https://ohtuvayrehcp.com	Whois	ohtuvayrehcp.com